Inside informationEnglish
Theranexus Becomes THX Pharma: A Strategic Evolution Toward the Commercialization of Its Medicines for Rare Diseases
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- THX Pharma
- Filed
- 29/09/2025, 18:30
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 076425_20250929